Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

BACKGROUND: The aim of this study is to determine whether immunohistochemical (IHC) assessment of Ki67 and p53 improves prognostication of oestrogen receptor-positive (ER+) breast cancer after breast-conserving therapy (BCT). In all, 498 patients with invasive breast cancer from a randomised trial o...

Descripción completa

Detalles Bibliográficos
Autores principales: Millar, E K A, Graham, P H, McNeil, C M, Browne, L, O'Toole, S A, Boulghourjian, A, Kearsley, J H, Papadatos, G, Delaney, G, Fox, C, Nasser, E, Capp, A, Sutherland, R L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142808/
https://www.ncbi.nlm.nih.gov/pubmed/21712826
http://dx.doi.org/10.1038/bjc.2011.228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142808/
https://www.ncbi.nlm.nih.gov/pubmed/21712826
http://dx.doi.org/10.1038/bjc.2011.228

Ejemplares similares